BACTILOC-DXL 200 TABLET
MRP: 222
Packaging: 10X10
Pack Type: tablet
Composition:
Cefpodoxime Proxetil 200mg + Dicloxacillin 500mg Extended Release
Indication:
sed to treat acute otitis media, pharyngitis and sinusitis
Description:
Cefpodoxime Proxetil 200 mg + Dicloxacillin 500 mg ER is a powerful combination of two broad-spectrum antibiotics, designed to tackle mixed bacterial infections, especially those caused by beta-lactamase-producing strains.
Cefpodoxime is a third-generation cephalosporin that acts against Gram-positive and Gram-negative bacteria.
Dicloxacillin, a penicillinase-resistant penicillin, targets Gram-positive cocci, particularly Staphylococcus aureus.
The extended-release formulation of Dicloxacillin ensures long-lasting plasma concentration, improving treatment outcomes and patient compliance. This combination is highly effective in treating skin & soft tissue infections, bone infections, ENT infections, and respiratory tract infections.
Tags:
- Broad-spectrum activity against Gram-positive & Gram-negative organisms
- Effective against penicillin-resistant staphylococci
- Long-acting formulation improves compliance
- Ideal for complicated SSTIs, bone infections, and ENT infections
- Lower risk of bacterial resistance when used appropriately
Usage Information
Dosage
Typical adult dose: 1 tablet (Cefpodoxime 200 mg + Dicloxacillin 500 mg ER) twice daily Take with food for better absorption Swallow whole; do not crush or chew Follow physician’s instructions regarding duration and frequency Complete full course to prevent bacterial resistance
Side Effects
Nausea, vomiting, or diarrhea Abdominal discomfort Skin rash or allergic reaction Headache or dizziness Rare: Antibiotic-associated colitis or liver enzyme elevation
Contraindications
Hypersensitivity to cephalosporins, penicillins, or beta-lactam antibiotics History of severe allergic reactions to antibiotics Use with caution in patients with renal or hepatic impairment Not for use in viral infections (e.g., flu, cold)